Jack R. Lazar - Nov 15, 2024 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Role
Director
Signature
/s/ Philip Mazzara, Attorney-in-Fact
Stock symbol
ALAB
Transactions as of
Nov 15, 2024
Transactions value $
-$1,080,439
Form type
4
Date filed
11/19/2024, 04:51 PM
Previous filing
Nov 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALAB Common Stock Sale -$534K -6.23K -4.61% $85.73 129K Nov 15, 2024 Direct F1, F2
transaction ALAB Common Stock Sale -$270K -3.12K -2.42% $86.61 126K Nov 15, 2024 Direct F1, F3
transaction ALAB Common Stock Sale -$215K -2.46K -1.96% $87.47 123K Nov 15, 2024 Direct F1, F4
transaction ALAB Common Stock Sale -$61.5K -697 -0.57% $88.29 123K Nov 15, 2024 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2024.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.0900 to $86.0650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.1000 to $87.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.1100 to $88.0850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.2400 to $88.4150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.